I agree that this site is using cookies. You can find further informations here.
X
POGGESI, I.
68  results:
Search for persons X
?
1

A translational model-based approach to inform the choice o..:

Tosca, E. M. ; Terranova, N. ; Stuyckens, K....
Cancer Chemotherapy and Pharmacology.  89 (2021)  1 - p. 117-128 , 2021
Link: https://doi.org/10.1007/..
 
?
2

A double-blind, placebo-controlled parallel group study to ..:

Marcer, A. ; Migliorini, F. ; Bettica, P....
European Urology Supplements.  18 (2019)  1 - p. e1428 , 2019
Link: https://doi.org/10.1016/..
 
?
3

IBRUTINIB INCREASES THE SYSTEMIC EXPOSURE OF RITUXIMAB: PHA..:

Cramer, P. ; Demirkan, F. ; Fraser, G....
Hematological Oncology.  35 (2017)  S2 - p. 232-233 , 2017
Link: https://doi.org/10.1002/..
 
?
4

Joint Modeling of Efficacy, Dropout, and Tolerability in Fl..:

Russu, A ; Marostica, E ; De Nicolao, G...
Clinical Pharmacology & Therapeutics.  91 (2012)  5 - p. 863-871 , 2012
Link: https://doi.org/10.1038/..
 
?
5

Estimation of Free Fexofenadine Concentrations at Histamine..:

Simons, K.J. ; Poggesi, I. ; Gillard, M...
Journal of Allergy and Clinical Immunology.  123 (2009)  2 - p. S103-S103 , 2009
Link: https://doi.org/10.1016/..
 
?
6

Testing additivity of anticancer agents in pre-clinical stu..:

Rocchetti, M. ; Del Bene, F. ; Germani, M....
European Journal of Cancer.  45 (2009)  18 - p. 3336-3346 , 2009
Link: https://doi.org/10.1016/..
 
?
7

Predicting the active doses in humans from animal studies: ..:

Rocchetti, M. ; Simeoni, M. ; Pesenti, E...
European Journal of Cancer.  43 (2007)  12 - p. 1862-1868 , 2007
Link: https://doi.org/10.1016/..
 
?
8

Pharmacokinetics and tolerability of exemestane in combinat..:

Traina, T. A. ; Poggesi, I. ; Robson, M....
Breast Cancer Research and Treatment.  111 (2007)  2 - p. 377-388 , 2007
Link: https://doi.org/10.1007/..
 
?
9

Computational approaches for predicting CYP-related metabol..:

Crivori, P. ; Poggesi, I.
European Journal of Medicinal Chemistry.  41 (2006)  7 - p. 795-808 , 2006
Link: https://doi.org/10.1016/..
 
?
10

A mathematical model to study the effects of drugs administ..:

Magni, P. ; Simeoni, M. ; Poggesi, I...
Mathematical Biosciences.  200 (2006)  2 - p. 127-151 , 2006
Link: https://doi.org/10.1016/..
 
?
11

112 Pharmacokinetic-pharmacodynamic (PK-PD) modeling of tum..:

Rocchetti, M. ; De Grassi, A. ; Simeoni, M....
European Journal of Cancer Supplements.  2 (2004)  8 - p. 36 , 2004
Link: https://doi.org/10.1016/..
 
?
12

113 Pharmacokinetic-pharmacodynamic (PK-PD) modeling of tum..:

Germani, M. ; Rocchetti, M. ; Simeoni, M....
European Journal of Cancer Supplements.  2 (2004)  8 - p. 37 , 2004
Link: https://doi.org/10.1016/..
 
?
13

Influence of a Two-Week Rifampicin Treatment on the Pharmac..:

Fuhr, R ; Jannuzzo, MG ; Poggesi, I...
BMC News and views.  2 (2002)  S1 - p. , 2002
Link: https://doi.org/10.1186/..
 
?
14

Pharmacokinetics (PK) of Aromasin® (exemestane, EXE) after ..:

Spinelli, R. ; Jannuzzo, M.G. ; Poggesi, I....
European Journal of Cancer.  35 (1999)  - p. S295 , 1999
Link: https://doi.org/10.1016/..
 
?
15

EFFECT OF RIFABUTIN ON ETHAMBUTOL PHARMACOKINETICS IN HEALT..:

BREDA, M. ; BENEDETTI, M.STROLIN ; BANI, M....
Pharmacological Research.  40 (1999)  4 - p. 351-356 , 1999
Link: https://doi.org/10.1006/..
 
1-15